US FDA approves Casgevy, cell-based gene therapy to treat transfusion-dependent beta-thalassemia EP News Bureau Jan 18, 2024 The approval signifies a second FDA-approved indication for Casgevy, as the product was also recently approved for the treatment…
FDA approves Tecartus, cell-based gene therapy to treat relapsed or refractory MCL in adults EP News Bureau Jul 25, 2020 It also received ‘Orphan Drug’ designation, which provides incentives to assist and encourage the development of drugs for rare…
